The Bone Morphogenetic Protein System in Mammalian Reproduction

Endocrine Reviews

Volumn 25, Issue 1, 2004, Pages 72-101

  Shimasaki, Shunichi ^a   Moore, R Kelly ^a   Otsuka, Fumio ^a   Erickson, Gregory F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 12; BONE MORPHOGENETIC PROTEIN 13; BONE MORPHOGENETIC PROTEIN 14; BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN 16; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 8; BONE MORPHOGENETIC PROTEIN 9; BONE MORPHOGENETIC PROTEIN RECEPTOR; GROWTH DIFFERENTIATION FACTOR 15; GROWTH DIFFERENTIATION FACTOR 5; LIGAND; MEMBRANE PROTEIN; OSTEOGENIC PROTEIN 1; OSTEOGENIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; BIOACCUMULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; FEMALE GENITAL SYSTEM; FERTILITY; FUTUROLOGY; GENE MUTATION; HYPOPHYSIS; HYPOTHALAMUS; KNOCKOUT MOUSE; MALE GENITAL SYSTEM; MAMMAL; MULTIGENE FAMILY; NONHUMAN; PHENOTYPE; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; FERTILITY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MICE; MICE, TRANSGENIC; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 0038150979     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2003-0007     Document Type: Review

References (318)

1. Urist MR 1965 Bone: formation by autoinduction. Science 150:893-899
2. Urist MR, Iwata H, Ceccotti PL, Dorfman RL, Boyd SD, McDowell RM, Chien C 1973 Bone morphogenesis in implants of insoluble bone gelatin. Proc Natl Acad Sci USA 70:3511-3515
3. Urist MR, Mikulski A, Lietze A 1979 Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 76:1828-1832
4. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA 1988 Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534
5. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV 1985 Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705
6. Kimelman D, Kirschner M 1987 Synergistic induction of mesoderm by FGF and TGF-β and the identification of an mRNA coding for FGF in the early Xenopus embryo. Cell 51:869-877
7. Mason AJ, Hayflick JS, Ling N, Esch F, Ueno N, Ying SY, Guillemin R, Niall H, Seeburg PH 1985 Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β. Nature 318:659-663
8. Padgett RW, St. Johnston RD, Gelbart WM 1987 A transcript from a Drosophila pattern gene predicts a protein homologous to the transforming growth factor-β family. Nature 325:81-84
9. Weeks DL, Melton DA 1987 A maternal mRNA localized to the vegetal hemisphere in Xenopus eggs codes for a growth factor related to TGF-β. Cell 51:861-867
10. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP, Fisher RA, Bertonis JM, Torres G, Wallner BP, Ramachandran KL, Ragin RC, Manganaro TF, MacLaughlin DT, Donahoe PK 1986 Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 45:685-698
11. Chang H, Brown CW, Matzuk MM 2002 Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocr Rev 23:787-823
12. Kessler E, Takahara K, Biniaminov L, Brusel M, Greenspan DS 1996 Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science 271:360-362
13. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM 1990 Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87:9843-9847
14. Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, Oppermann H 1990 OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J 9:2085-2093
15. Ozkaynak E, Schnegelsberg PNJ, Jin DF, Clifford GM, Warren FD, Drier EA, Oppermann H 1992 Osteogenic protein-2. A new member of the transforming growth factor-β superfamily expressed early in embryogenesis. J Biol Chem 267:25220-25227
16. McPherron AC, Lee S-J 1993 GDF-3 and GDF-9: two new members of the transforming growth factor-β superfamily containing a novel pattern of cysteines. J Biol Chem 268:3444-3449
17. Chang SC, Hoang B, Thomas JT, Vukicevic S, Luyten FP, Ryba NJ, Kozak CA, Reddi AH, Moos Jr M 1994 Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-β superfamily predominantly expressed in long bones during human embryonic development. J Biol Chem 269:28227-28234
18. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee S-J 1994 Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily. Nature 368:639-643
19. Gouédard L, Chen YG, Thevenet L, Racine C, Bone S, Lamarre I, Josso N, Massague J, di Clemente N 2000 Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. J Biol Chem 275:27973-27978
20. Visser JA, Olaso R, Verhoef-Post M, Kramer P, Themmen APN, Ingraham HA 2001 The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling. Mol Endocrinol 15:936-945
21. Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK 2001 Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression. Mol Endocrinol 15:946-959
22. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR 2002 Requirement of Bmpr1a for Müllerian duct regression during male sexual development. Nat Genet 32:408-414
23. Lee MM, Donahoe PK 1993 Müllerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 14:152-164
24. Josso N, Racine C, di Clemente N, Rodolfo Rey, Xavier F 1998 The role of anti-Müllerian hormone in gonadal development. Mol Cell Endocrinol 145:3-7
25. Durlinger ALL, Visser JA, Themmen APN 2002 Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 124:601-609
26. Josso N, Clemente N 2003 Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-β family. Trends Endocrinol Metab 14:91-97
27. Hogan BLM 1996 Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594
28. Balemans W, Van Hul W 2002 Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250:231-250
29. Zhao G-Q, Hogan BLM 1996 Evidence that mouse Bmp8a (Op2) and Bmp8b are duplicated genes that play a role in spermatogenesis and placental development. Mech Dev 57:159-168
30. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM 1998 The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12:1809-1817
31. Laitinen M, Vuojolainen K, Jaatinen R, Ketola I, Aaltonen J, Lehtonen E, Heikinheimo M, Ritvos O 1998 A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech Dev 78:135-140
32. Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S, Ueno N, Sampath K, Chang RJ, Erickson GF 1999 A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA 96:7282-7287
33. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk M 1996 Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383:531-535
34. Zhao GQ, Deng K, Labosky PA, Liaw L, Hogan BL 1996 The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev 10:1657-1669
35. Hayashi M, McGee EA, Min G, Klein C, Rose UM, van Duin M, Hsueh AJ 1999 Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology 140:1236-1244
36. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM 1999 Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 13:1035-1048
37. Otsuka F, Yao Z, Lee TH, Yamamoto S, Erickson GF, Shimasaki S 2000 Bone morphogenetic protein-15: identification of target cells and biological functions. J Biol Chem 275:39523-39528
38. Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW, Beattie AE, Davis GH, Ritvos O 2000 Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 25:279-283
39. Otsuka F, Moore RK, Shimasaki S 2001 Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem 276:32889-32895
40. Wilson T, Wu X-Y, Juengel JL, Ross IK, Lumsden JM, Lord EA, Dodds KG, Walling GA, McEwan JC, O'Connell AR, McNatty KP, Montgomery GW 2001 Highly prolific Booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells. Biol Reprod 64:1225-1235
41. Mulsant P, Lecerf F, Fabre S, Schibler L, Monget P, Lanneluc I, Pisselet C, Riquet J, Monniaux D, Callebaut I, Cribiu E, Thimonier J, Teyssier J, Bodin L, Cognie Y, Chitour N, Elsen JM 2001 Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Merino ewes. Proc Natl Acad Sci USA 98:5104-5109
42. Souza CJH, MacDougall C, Campbell BK, McNeilly AS, Baird DT 2001 The Booroola (FecB) phenotype is associated with a mutation in the bone morphogenetic receptor type 1B (BMPR1B) gene. J Endocrinol 169:R1-R6
43. Schlunegger MP, Grütter MG 1992 An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-β 2. Nature 358:430-434
44. Griffith DL, Keck PC, Sampath TK, Rueger DC, Carlson WD 1996 Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor β superfamily. Proc Natl Acad Sci USA 93:878-883
45. Vitt UA, Hsu SY, Hsueh AJW 2001 Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol Endocrinol 15:681-694
46. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, Luxenberg DH, McQuid D, Moutsatsos IK, Nove J, Wozney JM 1990 Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220-2224
47. Israel DI, Nove J, Kerns KM, Moutsatsos IK, Kaufman RJ 1992 Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. Growth Factors 7:139-150
48. Jones WK, Richmond EA, White K, Sasak H, Kusmik W, Smart J, Oppermann H, Rueger DC, Tucker RF 1994 Osteogenic protein-1 (OP-1) expression and processing in Chinese hamster ovary cells: isolation of a soluble complex containing the mature and pro-domains of OP-1. Growth Factors 11:215-225
49. Aono A, Hazama M, Notoya K, Taketomi S, Yamasaki H, Tsukuda R, Sasaki S, Fujisawa Y 1995 Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun 210:670-677
50. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA, Wozney JM 1996 Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13:291-300
51. Suzuki A, Kaneko E, Maeda J, Ueno N 1997 Mesoderm induction by BMP-4 and -7 heterodimers. Biochem Biophys Res Commun 232:153-156
52. Kusumoto K, Bessho K, Fujimura K, Akioka J, Ogawa Y, lizuka T 1997 Comparison of ectopic osteoinduction in vivo by recombinant human BMP-2 and recombinant Xenopus BMP-4/7 heterodimer. Biochem Biophys Res Commun 239:575-579
53. Liao WX, Moore RK, Otsuka F, Shimasaki S 2003 Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9: implication of the aberrant ovarian phenotype of BMP-15 mutant sheep. J Biol Chem 278:3713-3719
54. Miyazono K, Hellman U, Wernstedt C, Heldin CH 1988 Latent high molecular weight complex of transforming growth factor β1. J Biol Chem 263:6407-6415
55. Thies RS, Chen TJ, Davies MV, Tomkinson KN, Pearson AA, Shakey QA, Wolfman NM 2000 GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18:251-259
56. Cheifetz S, Weatherbee JA, Tsang ML, Anderson JK, Mole JE, Lucas R, Massague J 1987 The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell 48:409-415
57. Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massagué J 1990 Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem 265:20533-20538
58. Mathews LS, Vale WW 1991 Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65:973-982
59. Attisano L, Wrana JL, Cheifetz S, Massague J 1992 Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68:97-108
60. Baarends WM, van Helmond MJ, Post M, van der Schoot PJ, Hoogerbrugge JW, de Winter JP, Uilenbroek JT, Karels B, Wilming LG, Meijers JH, Themmen APN, Grootegoed JA 1994 A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct. Development 120:189-197
61. di Clemente N, Wilson CA, Faure E, Boussin L, Carmillo P, Tizard R, Picard JY, Vigier B, Josso N, Cate R 1994 Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol 8:1006-1020
62. Kawabata M, Chytil A, Moses HL 1995 Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-β receptor. J Biol Chem 270:5625-5630
63. Liu F, Ventura F, Doody J, Massagué J 1995 Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15:3479-3486
64. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K 1995 Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632-7636
65. Nohno T, Ishikawa T, Saito T, Hosokawa K, Noji S, Wolsing DH, Rosenbaum JS 1995 Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 270:22522-22526
66. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF 1992 Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell [Erratum (1992) 70: 1069] 68:775-785
67. ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K 1993 Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8:2879-2887
68. Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K 1993 Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75:681-692
69. Tsuchida K, Mathews LS, Vale WW 1993 Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Proc Natl Acad Sci USA 90:11242-11246
70. ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, Heldin CH 1994 Characterization of type I receptors for transforming growth factor-β and activin. Science 264:101-104
71. Yamaji N, Celeste AJ, Thies RS, Song JJ, Bernier SM, Goltzman D, Lyons KM, Nove J, Rosen V, Wozney JM 1994 A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4. Biochem Biophys Res Commun 205:1944-1951
72. Tsuchida K, Sawchenko PE, Nishikawa S-I, Vale WW 1996 Molecular cloning of a novel type 1 receptor serine/threonine kinase for the TGF-β superfamily from rat brain. Mol Cell Neurosci 7:467-478
73. Ebisawa T, Tada K, Kitajima I, Tojo K, Sampeth TK, Kawabata M, Miyazono K, Imamura T 1999 Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci 112:3519-3527
74. Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin CH, Miyazono K 1995 Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 130:217-226
75. Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K 1996 Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271:21345-21352
76. Moore RK, Otsuka F, Shimasaki S 2003 Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem 278:304-310
77. Vitt UA, Mazerbourg S, Klein C, Hsueh AJ 2002 Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol Reprod 67:473-480
78. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K 1994 Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269:16985-16988
79. Natsume T, Tomita S, Iemura S, Kinto N, Yamaguchi A, Ueno N 1997 Interaction between soluble type I receptor for bone morphogenetic protein and bone morphogenetic protein-4. J Biol Chem 272:11535-11540
80. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL 1998 Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 273:25628-25636
81. Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, Knaus P 2000 Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 11:1023-1035
82. Aoki H, Fujii M, Imamura T, Takehara K, Kato M, Miyazono K 2001 Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci 114:1483-1489
83. Fujii M, Takeda K, Imamura T, Aoki H, Sampath TK, Enomoto S, Kawabata M, Kato M, Ichijo H, Miyazono K 1999 Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 10:3801-3813
84. Miyazono K 2000 TGF-β signaling by Smad proteins. Cytokine Growth Factor Rev 11:15-22
85. Attisano L, Carcamo J, Ventura F, Weis FMB, Massague J, Wrana JL 1993 Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75:671-680
86. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, Knaus P 2002 The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277:5330-5338
87. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massague J 1992 TGF β signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014
88. Heldin C-H, Miyazono K, ten Dijke P 1997 TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471
89. Attisano L, Wrana JL 2000 Smads as transcriptional co-modulators. Curr Opin Cell Biol 12:235-243
90. ten Dijke P, Goumans M-J, Itoh F, Itoh S 2002 Regulation of cell proliferation by Smad proteins. J Cell Physiol 191:1-16
91. Lagna G, Hata A, Hemmati-Brivanlou A, Massague J 1996 Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways. Nature 383:832-836
92. Liu F, Pouponnot C, Massagué J 1997 Dual role of the Smad4/DPC4 tumor suppressor in TGF β-inducible transcriptional complexes. Genes Dev 11:3157-3167
93. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T 1998 Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 273:1872-1879
94. Miyazono K, Kusanagi K, Inoue H 2001 Divergence and convergence of TGF-β/BMP signaling. J Cell Physiol 187:265-276
95. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K 2002 Two major Smad pathways in TGF-β superfamily signalling. Genes Cells 7:1191-1204
96. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L 1996 MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552
97. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL 1996 MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215-1224
98. Zhang Y, Feng X, We R, Derynck R 1996 Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383:168-172
99. Graff JM, Bansal A, Melton DA 1996 Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85:479-487
100. Baker JC, Harland RM 1996 A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev 10:1880-1889
101. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L, Wrana JL 1996 MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85:489-500
102. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM, Massague J 1996 A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381:620-623
103. Chen Y, Bhushan A, Vale W 1997 Smad8 mediates the signaling of the receptor serine kinase. Proc Natl Acad Sci USA 94:12938-12943
104. Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T 1997 Smad1 and Smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 238:574-580
105. Tamaki K, Souchelnytskyi S, Itoh S, Nakao A, Sampath K, Heldin CH, ten Dijke P 1998 Intracellular signaling of osteogenic protein-1 through Smad5 activation. J Cell Physiol 177:355-363
106. Attisano L, Wrana JL 2002 Signal transduction by the TGF-β superfamily. Science 296:1646-1647
107. Chen Y-G, Massague J 1999 Smad1 recognition and activation by the ALK1 group of transforming growth factor-β family receptors. J Biol Chem 274:3672-3677
108. Roh JS, Bondestam J, Mazerbourg S, Kaivo-Oja N, Groome N, Ritvos O, Hsueh AJ 2003 Growth differentiation factor-9 stimulates inhibin production and activates Smad2 in cultured rat granulosa cells. Endocrinology 144:172-178
109. Kaivo-Oja N, Bondestam J, Kamarainen M, Koskimies J, Vitt U, Cranfield M, Vuojolainen K, Kallio JP, Olkkonen VM, Hayashi M, Moustakas A, Groome NP, ten Dijke P, Hsueh AJ, Ritvos O 2003 Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells. J Clin Endocrinol Metab 88:755-762
110. Iwasaki S, Iguchi M, Watanabe K, Hoshino R, Tsujimoto M, Kohno M 1999 Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC 12 cells by bone morphogenetic protein-2. J Biol Chem 274:26503-26510
111. Kimura N, Matsuo R, Shibuya H, Nakashima K, Taga T 2000 BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 275:17647-17652
112. Piek E, Heldin CH, ten Dijke P 1999 Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 13:2105-2124
113. Von Bubnoff A, Cho KWY 2001 Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev Biol 239:1-14
114. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K 1995 Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2008-2011
115. Nakamura K, Shirai T, Morishita S, Uchida S, Saeki-Miura K, Makishima F 1999 p38 Mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differenti-ation factor-5 in ATDC5 cells. Exp Cell Res 250:351-363
116. Palcy S, Goltzman D 1999 Protein kinase signalling pathways involved in the up-regulation of the rat α1(I) collagen gene by transforming growth factor β1 and bone morphogenetic protein 2 in osteoblastic cells. Biochem J 343:21-27
117. Gallea S, Lallemand F, Atfi A 2001 Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28:491-498
118. Su Y-Q, Wigglesworth K, Pendola FL, O'Brien MJ, Eppig JJ 2002 Mitogen-activated protein kinase activity in cumulus cells is essential for gonadotropin-induced oocyte meiotic resumption and cumulus expansion in the mouse. Endocrinology 143:2221-2232
119. Kretzschmar M, Doody J, Massague J 1997 Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389:618-622
120. Ueno N, Ling N, Ying S, Esch F, Shimasaki S, Guilleman R 1987 Isolation and partial characterization of follistatin: a novel Mr 35,000 monomeric protein which inhibits the release of follicle stimulating hormone. Proc Natl Acad Sci USA 84:8282-8286
121. Robertson DM, Klein R, de Vos FL, McLachlan RI, Wettenhall RE, Hearn MT, Burger HG, de Kretser DM 1987 The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem Biophys Res Commun 149:744-749
122. Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying SY, Ling N, Guillemin R 1988 Primary structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci USA 85:4218-4222
123. Shimasaki S, Koga M, Esch F, Mercado M, Cooksey K, Koba A, Ling N 1988 Porcine follistatin gene structure supports two forms of mature follistatin produced by alternative splicing. Biochem Biophys Res Commun 152:717-723
124. Shimasaki S, Koga M, Buscaglia ML, Simmons DM, Bicsak TA, Ling N 1989 Follistatin gene expression in the ovary and extragonadal tissues. Mol Endocrinol 3:651-659
125. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H 1990 Activin-binding protein from rat ovary is follistatin. Science 247:836-838
126. Phillips DJ, de Kretser DM 1998 Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol 19:287-322
127. Iemura S, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N 1998 Direct binding of follistatin to a complex of bone morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 95:9337-9342
128. Otsuka F, Moore RK, Iemura S-I, Ueno N, Shimasaki S 2001 Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem Biophys Res Commun 289:961-966
129. Guo Q, Kumar TR, Woodruff T, Hadsell LA, DeMayo FJ, Matzuk MM 1998 Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol 12:96-106
130. Matzuk MM, Kumar T, Bradley A 1995 Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374:356-360
131. Matzuk MM, Kumar TR, Vassalli A, Bickenbach JR, Roop DR, Jaenisch R, Bradley A 1995 Functional analysis of activins during mammalian development. Nature 374:354-356
132. Vassalli A, Matzuk MM, Gardner H, Lee K, Jaenisch R 1994 Activin/inhibin β B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev 8:414-427
133. Hayette S, Gadoux M, Martel S, Bertrand S, Tigaud I, Magaud JP, Rimokh R 1998 FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 16:2949-2954
134. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H 2000 Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-β family. J Biol Chem 275:40788-40796
135. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL 2001 Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology 142:3426-3434
136. Amthor H, Christ B, Rashid-Doubell F, Kemp CF, Lang E, Patel K 2002 Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth. Dev Biol 243:115-127
137. Abreu JG, Ketpura NI, Reversade B, De Robertis EM 2002 Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat Cell Biol 4:599-604
138. Wandji SA, Gadsby JE, Barber JA, Hammond JM 2000 Messenger ribonucleic acids for MAC25 and connective tissue growth factor (CTGF) are inversely regulated during folliculogenesis and early luteogenesis. Endocrinology 141:2648-2657
139. Slee RB, Hillier SG, Largue P, Harlow CR, Miele G, Clinton M 2001 Differentiation-dependent expression of connective tissue growth factor and lysyl oxidase messenger ribonucleic acids in rat granulosa cells. Endocrinology 142:1082-1089
140. Harlow CR, Davidson L, Burns KH, Yan C, Matzuk MM, Hillier SG 2002 FSH and TGF-β superfamily members regulate granulosa cell connective tissue growth factor gene expression in vitro and in vivo. Endocrinology 143:3316-3325
141. Harlow CR, Hillier SG 2002 Connective tissue growth factor in the ovarian paracrine system. Mol Cell Endocrinol 187:23-27
142. Smith WC, Harland RM 1992 Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 70:829-840
143. Zimmerman LB, De Jesus-Escobar JM, Harland RM 1996 The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86:599-606
144. Merino R, Macias D, Ganan Y, Economides AN, Wang X, Wu Q, Stahl N, Sampath KT, Varona P, Hurle JM 1999 Expression and function of gdf-5 during digit skeletogenesis in the embryonic chick leg bud. Dev Biol 206:33-45
145. Groppe J, Greenwald J, Wiater E, Rodriguez 2002 Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420:636-642
146. Marcelino J, Sciortino CM, Romero MF, Ulatowski LM, Ballock RT, Economides AN, Eimon PM, Harland RM, Warman ML 2001 Human disease-causing NOG missense mutations: effects on noggin secretion, dimer formation, and bone morphogenetic protein binding. Proc Natl Acad Sci USA 98:11353-11358
147. Sasai Y, Lu B, Steinbeisser H, Geissert D, Gont L, De Robertis EM 1994 Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell 79:779-790
148. Piccolo S, Sasai Y, Lu B, De Robertis EM 1996 Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86:589-598
149. Nakayama N, Han CE, Scully S, Nishinakamura R, He C, Zeni L, Yamane H, Chang D, Yu D, Yokota T, Wen D 2001 A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages. Dev Biol 232:372-387
150. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM 1998 The Xenopus dorsalizing factor gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1:673-683
151. Pearce JJH, Penny G, Rossant J 1999 A mouse cerberus/Danrelated gene family. Dev Biol 209:98-110
152. Martens JW, de Winter JP, Timmerman MA, McLuskey A, van Schaik RH, Themmen AP, de Jong FH 1997 Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells. Endocrinology 138:2928-2936
153. Lebrun JJ, Vale WW 1997 Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Mol Cell Biol 17:1682-1691
154. Bernard DJ, Chapman SC, Woodruff TK 2002 Minireview: inhibin binding protein (InhBP/p120), betaglycan, and the continuing search for the inhibin receptor. Mol Endocrinol 16:207-212
155. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W 2000 Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404:411-414
156. Wiater E, Vale W 2003 Inhibin is an antagonist of bone morphogenetic protein signaling. J Biol Chem 278:7934-7941
157. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone Jr MA, Wrana JL, Falb D 1997 The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89:1165-1173
158. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K 1997 Smad6 inhibits signalling by the TGF-β superfamily. Nature 389:622-626
159. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, ten Dijke P 1997 Identification of Smad7, a TGF β-inducible antagonist of TGF-β signalling. Nature 389:631-635
160. Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A 1998 Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12:186-197
161. Miyazono K 2000 Positive and negative regulation of TGF-β signaling. J Cell Sci 113:1101-1109
162. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J, Niehrs C 1999 Silencing of TGF-β signaling by the pseudoreceptor BAMBI. Nature 401:480-485
163. Grotewold L, Plum M, Dildrop R, Peters T, Ruether U 2001 Bambi is coexpressed with Bmp-4 during mouse embryogenesis. Mech Dev 100:327-330
164. Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, Donahoe PK 1996 The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell 86:435-444
165. Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH 1999 A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400:687-693
166. McLaren A 1999 Signaling for germ cells. Genes Dev 13:373-376
167. Saitou M, Barton SC, Surani MA 2002 A molecular programme for the specification of germ cell fate in mice. Nature 418:293-300
168. Eddy EM, Clark JM, Gong D, Fenderson BA 1981 Origin and migration of primordial germ cells in mammals. Gamete Res 4:333-362
169. Ying Y, Qi X, Zhao G-Q 2001 Induction of primordial germ cells from murine epiblasts by synergistic action of BMP4 and BMP8B signaling pathways. Proc Natl Acad Sci USA 98:7858-7862
170. Lawson KA, Dunn NR, Roelen BA, Zeinstra LM, Davis AM, Wright CV, Korving JP, Hogan BL 1999 Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev 13:424-436
171. Ying Y, Liu XM, Marble A, Lawson KA, Zhao GQ 2000 Requirement of Bmp8b for the generation of primordial germ cells in the mouse. Mol Endocrinol 14:1053-1063
172. Scully KM, Rosenfeld MG 2002 Pituitary development: regulatory codes in mammalian organogenesis. Science 295:2231-2235
173. Dasen JS, O'Connell SM, Flynn SE, Treier M, Gleiberman AS, Szeto DP, Hooshmand F, Aggarwal AK, Rosenfeld MG 1999 Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 97:587-598
174. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG 1998 Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12:1691-1704
175. Huang H-J, Wu JC, Su P, Zhirnov O, Miller WL 2001 A novel role for bone morphogenetic proteins in the synthesis of follicle-stimulating hormone. Endocrinology 142:2275-2283
176. Otsuka F, Shimasaki S 2002 A novel function of bone morphogenetic protein-15 in the pituitary: selective synthesis and secretion of FSH by gonadotropes. Endocrinology 143:4938-4941
177. Fitzpatrick SL, Sindoni DM, Shughrue PJ, Lane MV, Merchenthaler IJ, Frail DE 1998 Expression of growth differentiation factor-9 messenger ribonucleic acid in ovarian and nonovarian rodent and human tissues. Endocrinology 139:2571-2578
178. Eckery DC, Whale LJ, Lawrence SB, Wylde KA, McNatty KP, Juengel JL 2002 Expression of mRNA encoding growth differentiation factor 9 and bone morphogenetic protein 15 during follicular formation and growth in a marsupial, the brushtail possum (Trichosurus vulpecula). Mol Cell Endocrinol 192:115-126
179. Cameron VA, Nishimura E, Mathews LS, Lewis KA, Sawchenko PE, Vale WW 1994 Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. Endocrinology 134:799-808
180. Erickson GF, Shimasaki S 2003 The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reprod Biol Endocrinol 1:9
181. Erickson GF 2001 The ovary: basic principles and concepts. In: Felig P, Frohman L, eds. Endocrinology and metabolism, 4th ed. New York: McGraw Hill; 707-743
182. Drummond AE, Le MT, Ethier J-F, Dyson ML, Findlay JK 2002 Expression and localization of activin receptors, Smads, and βglycan to the postnatal rat ovary. Endocrinology 143:1423-1433
183. Souza CJH, Campbell BK, McNeilly AS, Baird DT 2002 Effect of bone morphogenetic protein 2 (BMP2) on oestradiol and inhibin A production by sheep granulosa cells, and localization of BMP receptors in the ovary by immunohistochemistry. Reproduction 123: 363-369
184. Yi SE, LaPolt PS, Yoon BS, Chen JYC, Lu JKH, Lyons KM 2001 The type I BMP receptor BmprIB is essential for female reproductive function. Proc Natl Acad Sci USA 98:7994-7999
185. Pangas SA, Rademaker AW, Fishman DA, Woodruff TK 2002 Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary. J Clin Endocrinol Metab 87:2644-2657
186. Lee W, Otsuka F, Moore RK, Shimasaki S 2001 The effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod 65:994-999
187. Vitt UA, McGee EA, Hayashi M, Hsueh AJW 2000 In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology 141:3814-3820
188. Bodensteiner KJ, Clay CM, Moeller CL, Sawyer HR 1999 Molecular cloning of the ovine growth/differentiation factor-9 gene and expression of growth/differentiation factor-9 in ovine and bovine ovaries. Biol Reprod 60:381-386
189. Aaltonen J, Laitinen MP, Vuojolainen K, Jaatinen R, Horelli-Kuitunen N, Seppa L, Louhio H, Tuuri T, Sjoberg J, Butzow R, Hovata O, Dale L, Ritvos O 1999 Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab 84:2744-2750
190. Bodensteiner KJ, McNatty KP, Clay CM, Moeller CL, Sawyer HR 2000 Expression of growth and differentiation factor-9 in the ovaries of fetal sheep homozygous or heterozygous for the Inverdale prolificacy gene (FecX(I)). Biol Reprod 62:1479-1485
191. Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, Shimasaki S, Erickson GF 2002 Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab 87:1337-1344
192. McGrath SA, Esquela AF, Lee S-J 1995 Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 9:131-136
193. Jaatinen R, Laitinen M, Vuojolainen K, Aaltonen J, Louhio H, Heikinheimo K, Lehtonen E, Ritvos O 1999 Localization of growth differentiation factor-9 (GDF-9) mRNA and protein in rat ovaries and cDNA cloning of rat GDF-9 and its novel homolog GDF-9B. Mol Cell Endocrinol 156:189-193
194. Elvin JA, Yan C, Matzuk MM 2000 Oocyte-expressed TGF-β superfamily members in female fertility. Mol Cell Endocrinol 159:1-5
195. Dodd JM 1977 The structure of the ovary of nonmammalian vertebrates. In: Zuckerman L, Weir BJ, eds. The ovary, 2nd ed. London: Academic Press; 219-263
196. Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL, Celeste AJ, Matzuk MM 2001 Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 15:854-866
197. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C 1985 The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 6:371-399
198. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM 1999 Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 13:1018-1034
199. Lyons KM, Pelton RW, Hogan BL 1989 Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-β-like genes coordinately regulate aspects of embryonic development. Genes Dev 3:1657-1668
200. Zhao J, Taverne MAM, van der Weijden GC, Bevers MM, van den Hurk R 2001 Effect of activin A on in vitro development of rat preantral follicles and localization of activin A and activin receptor II. Biol Reprod 65:967-977
201. Erickson GF, Shimasaki S 2002 Morphologic and physiologic correlates of the PCOS ovary. In: Chang RJ, Dunaif A, Heindel JJ, eds. Polycystic ovary syndrome. New York: Marcel Dekker, Inc.; 55-62
202. Hurwitz A, Adashi EY 1992 Ovarian follicular atresia as an apoptotic process: a paradigm for programmed cell death in endocrine tissues. Mol Cell Endocrinol 84:C19-C23
203. Hsueh AJ, Billig H, Tsafriri A 1994 Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 15:707-724
204. Tilly JL 1996 Apoptosis and ovarian function. Rev Reprod 1:162-172
205. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH 1992 Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267:20352-20362
206. Dudley AT, Lyons KM, Robertson EJ 1995 A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807
207. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G 1995 BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820
208. Falck B 1959 Site of production of oestrogen in rat ovary as studied in micro-transplants. Acta Physiologica Scandinavica 47:1-101
209. Nalbandov AV 1970 Oogenesis. In: Biggers JD, Schuetz AW, eds. Symposium on oogenesis. Baltimore: Johns Hopkins University, School of Hygiene and Public Health; 513-522
210. El-Fouly MA, Cook B, Nekola M, Nalbandov AV 1970 Role of the ovum in follicular luteinization. Endocrinology 87:288-293
211. Hubbard GM, Erickson GF 1988 Luteinizing hormone (LH) --ndependent luteinization and ovulation in hypophysectomized rat: a possible role for the oocyte. Biol Reprod 39:183-194
212. Erickson GF, Shimasaki S 2000 The role of the oocyte in folliculogenesis. Trends Endocrinol Metab 11:193-198
213. Otsuka F, Yamamoto S, Erickson GF, Shimasaki S 2001 Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J Biol Chem 276:11387-11392
214. Vitt UA, Hayashi M, Klein C, Hsueh AJW 2000 Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 62:370-377
215. Yokouchi Y, Sakiyama J, Kameda T, Iba H, Suzuki A, Ueno N, Kuroiwa A 1996 BMP-2/-4 mediate programmed cell death in chicken limb buds. Development 122:3725-3734
216. Song Q, Mehler MF, Kessler JA 1998 Bone morphogenetic proteins induce apoptosis and growth factor dependence of cultured sympathoadrenal progenitor cells. Dev Biol 196:119-127
217. Hay E, Lemonnier J, Fromigue O, Marie PJ 2001 Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276:29028-29036
218. Kawamura C, Kizaki M, Ikeda Y 2002 Bone morphogenetic protein (BMP)-2 induces apoptosis in human myeloma cells. Leuk Lymphoma 43:635-639
219. Auersperg N, Wong AST, Choi K-C, Kang SK, Leung PCK 2001 Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22:255-288
220. Murdoch WJ, McDonnel AC 2002 Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123:743-750
221. Matzuk MM, Finegold MJ, Su J-GJ, Hsueh AJW, Bradley A 1992 α-Inhibin is a rumor-suppressor gene with gonadal specificity in mice. Nature 360:313-319
222. Matzuk MM, Kumar TR, Shou W, Coerver KA, Lau AL, Behringer RR, Finegold MJ 1996 Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res 51:123-157
223. Lyons K, Graycar JL, Lee A, Hashmi S, Lindquist PB, Chen EY, Hogan BL, Derynck R 1989 Vgr-1, a mammalian gene related to Xenopus Vg-1, is a member of the transforming growth factor β gene superfamily. Proc Natl Acad Sci USA 86:4554-4558
224. Ozkaynak E, Jin DF, Jelic M, Vukicevic S, Oppermann H 1997 Osteogenic protein-1 mRNA in the uterine endometrium. Biochem Biophys Res Commun 234:242-246
225. Cunningham NS, Jenkins NA, Gilbert DJ, Copeland NG, Reddi AH, Lee SJ 1995 Growth/differentiation factor-10: a new member of the transforming growth factor-β superfamily related to bone morphogenetic protein-3. Growth Factors 12:99-109
226. Ying Y, Zhao G-Q 2000 Detection of multiple bone morphogenetic protein messenger ribonucleic acids and their signal transducer, Smad1, during mouse decidualization. Biol Reprod 63:1781-1786
227. Coucouvanis E, Martin GR 1999 BMP signaling plays a role in visceral endoderm differentiation and cavitation in the early mouse embryo. Development 126:535-546
228. Paria BC, Ma W, Tan J, Raja S, Das SK, Dey SK, Hogan BL 2001 Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. Proc Natl Acad Sci USA 98:1047-1052
229. Zhao GQ, Liaw L, Hogan BL 1998 Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis. Development 125:1103-1112
230. Kaiser M, Gibori G, Mayo KE 1990 The rat follistatin gene is highly expressed in decidual tissue. Endocrinology 126:2768-2770
231. Fujiwara T, Dunn NR, Hogan BLM 2001 Bone morphogenetic protein 4 in the extraembryonic mesoderm is required for allantois development and the localization and survival of primordial germ cells in the mouse. Proc Natl Acad Sci USA 98:13739-13744
232. Martinovic S, Latin V, Suchanek E, Stavljenic-Rukavina A, Sampath KT, Vukicevic S 1996 Osteogenic protein-1 is produced by human fetal trophoblasts in vivo and regulates the synthesis of chorionic gonadotropin and progesterone by trophoblasts in vitro. Eur J Clin Chem Clin Biochem 34:103-109
233. Hromas R, Hufford M, Sutton J, Xu D, Li Y, Lu L 1997 PLAB, a novel placental bone morphogenetic protein. Biochim Biophys Acta 1354:40-44
234. Paralkar VM, Vail AL, Grasser WA, Brown TA, Xu H, Vukicevic S, Ke HZ, Qi H, Owen TA, Thompson DD 1998 Cloning and characterization of a novel member of the transforming growth factor-β/bone morphogenetic protein family. J Biol Chem 273: 13760-13767
235. Poggi SH, Bostrom KI, Demer LL, Skinner HC, Koos BJ 2001 Placental calcification: a metastatic process? Placenta 22:591-596
236. Phippard DJ, Weber-Hall SJ, Sharpe PT, Naylor MS, Jayatalake H, Maas R, Woo I, Roberts-Clark D, Francis-West PH, Liu YH, Maxson R, Hill RE, Dale TC 1996 Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. Development 122:2729-2737
237. Clement JH, Marr N, Meissner A, Schwalbe M, Sebald W, Kliche KO, Hoffken K, Wolfl S 2000 Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 126:271-279
238. Zhao G-Q, Chen Y-X, Liu X-M, Xu Z, Qi X 2001 Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis. Dev Biol 240:212-222
239. Zhao G-Q, Hogan BLM 1997 Evidence that mothers-against-dpp-related 1 (Madr1) plays a role in the initiation and maintenance of spermatogenesis in the mouse. Mech Dev 61:63-73
240. Chen MY, Carpenter D, Zhao G-Q 1999 Expression of bone morphogenetic protein 7 in murine epididymis is developmentally regulated. Biol Reprod 60:1503-1508
241. Gray DP, Huether SE 1990 Alterations of the reproductive systems. In: McCance KL, Huether SE, eds. Pathophysiology: the biologic basis for disease in adults and children. St. Louis, MO: The C.V. Mosby Company; 677-724
242. Thomas R, Anderson WA, Raman V, Reddi AH 1998 Androgen-dependent gene expression of bone morphogenetic protein 7 in mouse prostate. Prostate 37:236-245
243. Harris SE, Harris MA, Mahy P, Wozney JM, Feng JQ, Mundy GR 1994 Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate 24:204-211
244. Barnes J, Anthony T, Wall N, Steiner MS 1995 Bone morphogenetic protein-6 expression in normal and malignant prostate. World J Urol 13:337-343
245. Winnier G, Blessing M, Labosky PA, Hogan BLM 1995 Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9:2105-2116
246. Yoshimura Y, Wallach EE 1987 Studies of the mechanism(s) of mammalian ovulation. Fertil Steril 47:22-34
247. Reich R, Miskin R, Tsafriri A 1985 Follicular plasminogen activator: involvement in ovulation. Endocrinology 116:516-521
248. Reich R, Tsafriri A, Mechanic GL 1985 The involvement of collagenolysis in ovulation in the rat. Endocrinology 116:522-527
249. Faletti A, Viggiano JM, Gimeno MAF 1995 β-Endorphin inhibits prostaglandin synthesis in rat ovaries and blocks induced ovulation. Prostaglandins 49:93-109
250. Faletti A, Jawerbaum A, Viggiano JM, Gimeno MAF 1997 Naltrexone enhances ovulation and prostaglandin synthesis in the rat ovary. Prostaglandins 54:665-675
251. Meyer RK, Karavolas HJ, Klausing M, Norgard DW 1971 Blood progesterone and pregnenolone levels during phenobarbital (PB) block of PMS-induced ovulation in immature rats. Endocrinology 88:983-990
252. Rao IM, Mahesh VB 1986 Role of progesterone in the modulation of the preovulatory surge of gonadotropins and ovulation in the pregnant mare's serum gonadotropin-primed immature rat and the adult rat. Biol Reprod 35:1154-1161
253. Mori T, Suzuki A, Nishimura T, Kambegawa A 1977 Inhibition of ovulation in immature rats by anti-progesterone antiserum. J Endocrinol 73:185-186
254. Dooley CA, Attia GR, Rainey WE, Moore DR, Carr BR 2000 Bone morphogenetic protein inhibits ovarian androgen production. J Clin Endocrinol Metab 85:3331-3337
255. Rainey WE, Sawetawan C, McCarthy JL, McGee EA, Bird IM, Word RA, Carr BR 1996 Human ovarian tumor cells: a potential model for thecal cell steroidogenesis. J Clin Endocrinol Metab 81: 257-263
256. B-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells. J Clin Endocrinol Metab 87:1254-1261
257. Matzuk M 2000 Revelations of ovarian follicle biology from gene knockout mice. Mol Cell Endocrinol 163:61-66
258. Eppig JJ 2001 Oocyte control of ovarian follicular development and function in mammals. Reproduction 122:829-838
259. Buccione R, Schroeder AC, Eppig JJ 1990 Interactions between somatic cells and germ cells throughout mammalian oogenesis. Biol Reprod 43:543-547
260. Wu X, Matzuk MM 2002 GDF-9 and BMP-15: oocyte organizers. Rev Endocr Metab Disord 3:27-32
261. Matzuk MM, Burns KH, Viveiros MM, Eppig JJ 2002 Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 296:2178-2180
262. Vanderhyden B 2002 Molecular basis of ovarian development and function. Front Biosci 7:d2006-d2022
263. Otsuka F, Shimasaki S 2002 A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis. Proc Natl Acad Sci USA 99:8060-8065
264. Manova K, Huang EJ, Angeles M, De Leon V, Sanchez S, Pronovost SM, Besmer P, Bachvarova RF 1993 The expression pattern of the c-kit ligand in gonads of mice supports a role for the c-kit receptor in oocyte growth and in proliferation of spermatogonia. Dev Biol 157:85-99
265. Ismail RS, Okawara Y, FryerJN, Vanderhyden BC 1996 Hormonal regulation of the ligand for c-kit in the rat ovary and its effects on spontaneous oocyte meiotic maturation. Mol Reprod Dev 43:458-469
266. Laitinen M, Rutanen E, Ritvos O 1995 Expression of c-kit ligand messenger ribonucleic acids in human ovaries and regulation of their steady state levels by gonadotropins in cultured granulosaluteal cells. Endocrinology 136:4407-4414
267. Driancourt MA, Reynaud K, Cortvrindt R, Smitz J 2000 Roles of KIT and KIT LIGAND in ovarian function. Rev Reprod 5:143-152
268. Manova K, Nocka K, Besmer P, Bachvarova RF 1990 Gonadal expression of c-kit encoded at the W locus of the mouse. Development 110:1057-1069
269. Orr-Urtreger A, Avivi A, Zimmer Y, Givol D, Yarden Y, Lonai P 1990 Developmental expression of c-kit, a proto-oncogene encoded by the W locus. Development 109:911-923
270. Horie K, Takakura K, Taii S, Narimoto K, Noda Y, Nishikawa S, Nakayama H, Fujita J, Mori T 1991 The expression of c-kit protein during oogenesis and early embryonic development. Biol Reprod 45:547-552
271. Albiston AL, Herington AC 1990 Cloning and characterization of the growth hormone dependent insulin-like growth factor binding protein IGFBP-30 in the rat. Biochem Biophys Res Commun 166: 892-897
272. Copeland NG, Gilbert DJ, Cho BC, Donovan PJ, Jenkins NA, Cosman D, Anderson D, Lyman SD, Williams DE 1990 Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 63:175-183
273. Flanagan JG, Leder P 1990 The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell 63:185-194
274. Huang E, Nocka K, Beier DR, Chu TY, Buck J, Lahm HW, Wellner D, Leder P, Besmer P 1990 The hematopoietic growth factor KL is encoded by the S1 locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225-233
275. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV 1990 Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213-224
276. Anderson DM, Lyman SD, Baird A, Wignall JM, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D, Williams DE 1990 Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell [Erratum (1990) 63:1112] 63:235-243
277. Packer AI, Hsu YC, Besmer P, Bachvarova RF 1994 The ligand of the c-kit receptor promotes oocyte growth. Dev Biol 161:194-205
278. Joyce IM, Pendola FL, Wigglesworth K, Eppig JJ 1999 Oocyte regulation of kit ligand expression in mouse ovarian follicles. Dev Biol 214:342-353
279. Vitt UA, Hsueh AJW 2001 Stage-dependent role of growth differentiation factor-9 in ovarian follicle development. Mol Cell Endocrinol 183:171-177
280. Yamamoto N, Christenson LK, McAllister JM, Strauss JF 2002 Growth differentiation factor-9 inhibits 3′5′-adenosine monophosphate-stimulated steroidogenesis in human granulosa and theca cells. J Clin Endocrinol Metab 87:2849-2856
281. Elvin JA, Yan C, Matzuk MM 2000 Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E2/EP2 receptor pathway. Proc Natl Acad Sci USA 97: 10288-10293
282. Varani S, Elvin JA, Yan C, DeMayo J, DeMayo FJ, Horton HF, Byrne MC, Matzuk MM 2002 Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol Endocrinol 16:1154-1167
283. Joyce IM, Clark AT, Pendola FL, Eppig JJ 2000 Comparison of recombinant growth differentiation factor-9 and oocyte regulation of KIT ligand messenger ribonucleic acid expression in mouse ovarian follicles. Biol Reprod 63:1669-1675
284. Nilsson EE, Skinner MK 2002 Growth and differentiation factor-9 stimulates progression of early primary but not primordial rat ovarian follicle development. Biol Reprod 67:1018-1024
285. Motro B, Bernstein A 1993 Dynamic changes in ovarian c-kit and Steel expression during the estrous reproductive cycle. Dev Dyn 197:69-79
286. Hreinsson JG, Scott JE, Rasmussen C, Swahn ML, Hsueh AJW, Hovatta O 2002 Growth differentiation factor-9 promotes the growth, development, and survival of human ovarian follicles in organ culture. J Clin Endocrinol Metab 87:316-321
287. Solovyeva EV, Hayashi M, Margi K, Barkats C, Klein C, Amsterdam A, Hsueh AJ, Tsafriri A 2000 Growth differentiation factor-9 stimulates rat theca-interstitial cell androgen biosynthesis. Biol Reprod 63:1214-1218
288. Bondestam J, Kaivo-oja N, Kallio J, Groome N, Hyden-Granskog C, Fujii M, Moustakas A, Jalanko A, ten Dijke P, Ritvos O 2002 Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells. Mol Cell Endocrinol 195:79-88
289. Moore RK, Otsuka F, Shimasaki S 2001 Role of ERK1/2 in the differential synthesis of progesterone and estradiol by granulosa cells. Biochem Biophys Res Commun 289:796-800
290. Keun Kang S, Tai C-J, Wa Cheng K, Leung PCK 2000 Gonadotropin-releasing hormone activates mitogen-activated protein kinase in human ovarian and placental cells. Mol Cell Endocrinol 170:143-151
291. Tai C-J, Kang SK, Tzeng C-R, Leung PCK 2001 Adenosine triphosphate activates mitogen-activated protein kinase in human granulosa-luteal cells. Endocrinology 142:1554-1560
292. Seger R, Hanoch T, Rosenberg R, Dantes A, Merz WE, Strauss 3rd JF, Amsterdam A 2001 The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem 276:13957-13964
293. Findlay JK, Drummond AE, Dyson ML, Baillie AJ, Robertson DM, Ethier J-F 2002 Recruitment and development of the follicle; the roles of the transforming growth factor-β superfamily. Mol Cell Endocrinol 191:35-43
294. Halvorson LM, Chin WW 1999 Gonadotropic hormones: biosynthesis, secretion, receptors, and action. In: Yen SC, Jaffe RB, Barbieri RL, eds. Reproductive endocrinology, 4th ed. Philadelphia: W.B. Saunders Co.; 81-109
295. Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R 1986 Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature 321:779-782
296. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J 1986 Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321: 776-779
297. Zhao G-Q 2003 Consequences of knocking out BMP signaling in the mouse. Genesis 35:43-56
298. Zhang H, Bradley A 1996 Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122:2977-2986
299. Oh SP, Li E 1997 The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev 11:1812-1826
300. Mishina Y, Suzuki A, Ueno N, Behringer RR 1995 Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 9:3027-3037
301. Beppu H, Kawabata M, Hamamoto T, Chytil A, Minowa O, Noda T, Miyazono K 2000 BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol 221: 249-258
302. Carabatsos MJ, Elvin J, Matzuk MM, Albertini DF 1998 Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev Biol 204:373-384
303. Davis GH, McEwan JC, Fennessy PF, Dodds KG, Farquhar PA 1991 Evidence for the presence of a major gene influencing ovulation rate on the X chromosome of sheep. Biol Reprod 44:620-624
304. Davis GH, McEwan JC, Fennessy PF, Dodds KG, McNatty KP,O WS 1992 Infertility due to bilateral ovarian hypoplasia in sheep homozygous (FecXI FecXI) for the Inverdale prolificacy gene located on the X chromosome. Biol Reprod 46:636-640
305. Braw-Tal R, McNatty KP, Smith P, Heath DA, Hudson NL, Phillips DJ, McLeod BJ, Davis GH 1993 Ovaries of ewes homozygous for the X-linked Inverdale gene (FecX-1) are devoid secondary and tertiary follicles but contain many abnormal structures. Biol Reprod 49:895-907
306. Davis GH, McEwan JC, Fennessy PF, Dodds KG, Discovery of the Inverdale gene (FecX). Proc of the New Zealand Society of Animal Production, Mosgiel, New Zealand, 1995, pp 289-290 (Abstract AB95092)
307. Shackell GH, Hudson NL, Heath DA, Lun S, Shaw L, Condell L, Blay LR, McNatty KP 1993 Plasma gonadotropin concentrations and ovarian characteristics in Inverdale ewes that are heterozygous for a major gene (FecX1) on the X chromosome that influences ovulation rate. Biol Reprod 48:1150-1156
308. Galloway SM, Gregan SM, Wilson T, McNatty KP, Juengel JL, Ritvos O, Davis GH 2002 Bmp15 mutations and ovarian function. Mol Cell Endocrinol 191:15-18
309. Juengel JL, Hudson NL, Heath DA, Smith P, Reader KL, Lawrence SB, O'Connell AR, Laitinen MP, Cranfield M, Groome NP, Ritvos O, McNatty KP 2002 Growth differentiation factor-9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep. Biol Reprod 67:1777-1789
310. Bindon BM 1984 Reproductive biology of the Booroola Merino sheep. Aust J Biol Sci 37:163-189
311. Fabre S, Pierre A, Pisselet C, Mulsant P, Lecerf F, Pohl J, Monget P, Monniaux D 2003 The Booroola mutation in sheep is associated with an alteration of the bone morphogenetic protein receptor-IB functionality. J Endocrinol 177:435-444
312. Montgomery GW, Galloway SM, Davis GH, McNatty KP 2001 Genes controlling ovulation rate in sheep. Reproduction 121:843-852
313. McNatty KP, Kieboom LE, McDiarmid J, Heath DA, Lun S 1986 Adenosine cyclic 3′,5′-monophosphate and steroid production by small ovarian follicles from Booroola ewes with and without a fecundity gene. J Reprod Fertil 76:471-480
314. Davis GH, Dodds KG, Bruce GD 1999 Combined effect of the inverdale and booroola prolificacy genes on ovulation rate in sheep. Proc Assoc Adv Anim Breed Genet 13:74-77
315. McNatty KP, Juengel JL, Wilson T, Galloway SM, Davis GH 2001 Genetic mutations influencing ovulation rate in sheep. Reprod Fertil Dev 13:549-555
316. Baur ST, Mai JJ, Dymecki SM 2000 Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity. Development 127: 605-619
317. Yi SE, Daluiski A, Pederson R, Rosen V, Lyons KM 2000 The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 127:621-630
318. Anderson RA, Baird DT 2002 Male contraception. Endocr Rev 23:735-762